Legend Biotech Updates Corporate Presentation
Ticker: LEGN · Form: 6-K · Filed: Jun 6, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Jun 6, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-presentation, investor-relations
TL;DR
Legend Biotech dropped a new investor deck, check their site for the latest.
AI Summary
On June 6, 2025, Legend Biotech Corporation announced it will make its updated corporate presentation available on its website and attached to this Form 6-K filing. The presentation can be accessed via the investor relations section of their website.
Why It Matters
This update provides investors with the latest information and strategic outlook directly from the company.
Risk Assessment
Risk Level: low — The filing is an update to a corporate presentation, not a material event like an acquisition or financial distress.
Key Players & Entities
- Legend Biotech Corporation (company) — Registrant
- June 6, 2025 (date) — Date of Report
- 2101 Cottontail Lane Somerset, New Jersey 08873 (address) — Principal executive office
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to announce that Legend Biotech Corporation is making its updated corporate presentation available on its website and has attached it as Exhibit 99.1.
When was this report filed?
This report was filed on June 6, 2025.
Where can investors find the updated corporate presentation?
Investors can find the updated corporate presentation on Legend Biotech's website at https://investors.legendbiotech.com/events-and-presentations.
What is Legend Biotech Corporation's principal executive office address?
Legend Biotech Corporation's principal executive office is located at 2101 Cottontail Lane, Somerset, New Jersey 08873.
Does Legend Biotech file annual reports under Form 20-F or 40-F?
Legend Biotech indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 6, 2025 regarding Legend Biotech Corp (LEGN).